• Collidion to buy 80% stake in Plex Pharmaceuticals pharmaceutical-technology
    August 04, 2017
    US-based healthcare company Collidion has entered a definitive agreement to purchase 80% equity stake in the early stage biotechnology company Plex Pharmaceuticals for an undisclosed amount.
PharmaSources Customer Service